﻿<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov:80/entrez/query/static/PubMed.dtd"[]>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Science and Education Publishing</PublisherName>
      <JournalTitle>American Journal of Cancer Prevention</JournalTitle>
      <Issn>2328-7314</Issn>
      <Volume>4</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2016</Year>
        <Month>4</Month>
        <Day>26</Day>
      </PubDate>
    </Journal>
    <ArticleTitle>Role of TACE in Patients with Hepatocellular Carcinoma before Liver Transplantation</ArticleTitle>
    <FirstPage>23</FirstPage>
    <LastPage>25</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Cheng</FirstName>
        <LastName>Luo</LastName>
      </Author>
      <Author>
        <FirstName>Yakun</FirstName>
        <LastName>Wu</LastName>
      </Author>
      <Author>
        <FirstName>Shaoyong</FirstName>
        <LastName>Liang</LastName>
        <Affiliation>Department of General Surgery, The Thirteenth People's Hospital of Chongqing, Chongqing 400010, China</Affiliation>
      </Author>
    </AuthorList>
    <ArticleIdList>
      <ArticleId IdType="pii">AJCP2016421</ArticleId>
      <ArticleId IdType="doi">10.12691/ajcp-4-2-1</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>11</Month>
        <Day>15</Day>
      </PubDate>
      <PubDate PubStatus="revised">
        <Year>2016</Year>
        <Month>2</Month>
        <Day>12</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2016</Year>
        <Month>4</Month>
        <Day>24</Day>
      </PubDate>
    </History>
    <Abstract>Transarterial chemoembolization (TACE) can prevent tumor progression in patients with hepatocellular carcinoma awaiting liver transplantation. This article introduces the effect of TACE before liver transplantation in terms of dropout rate, improvement in overall survival, prediction of survival, and its application as down-stage therapy.</Abstract>
  </Article>
</ArticleSet>